RecruitingNCT05044767

Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty

Observational and Prospective Multicenter Study to Evaluate the Long-term (10 Years) Performance and Safety (10 Years) of ATF Implants and Lapé Médical Devices Implanted During Total Hip Arthroplasty or Hemiarthroplasty.


Sponsor

ATF Implants

Enrollment

4,500 participants

Start Date

Jun 7, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Observational and prospective multicenter study to evaluate the long-term (10 years) performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during total hip arthroplasty or hemiarthroplasty.


Eligibility

Inclusion Criteria17

  • Male or female indicated for hip replacement surgery with hip prosthesis manufactured by ATF Implants and/or Lapé médical;
  • There are different indications for hip replacement surgery. The main ones are listed below:
  • Dysplasia
  • Primary Coxarthrosis
  • Secondary Coxarthrosis
  • Perthes disease
  • Epiphysiolysis
  • Ankylosing spondylitis
  • Trochanteric bursitis
  • Arthritis
  • Degenerative arthritis
  • Post-traumatic arthritis
  • Rheumatoid arthritis
  • Femoral neck fracture
  • Osteonecrosis
  • Revision
  • Depending on the specificities of the devices (size, absence/presence of a coating, material), indications may vary. This information can be found in the instruction for use. It is the surgeon's responsibility to select the most appropriate prosthesis for a given patient according to the patient's medical records and the instruction for use in force at the time of the procedure accompanying the medical device.

Exclusion Criteria6

  • There are various contraindications for hip arthroplasty. The main ones are listed below:
  • An acute or chronic, local or systemic infection
  • Severe muscular, neurological or vascular deficiency compromising the affected extremity
  • A bone defect or insufficient bone quality that may compromise the stability of the implant
  • Any concomitant disease (dysplastic coxarthrosis with extreme coxa valga, short neck and severe varus) that may affect the function of the implant
  • Sensitivity to the material (allergy) Depending on the specificities of the devices (size, absence/presence of a coating, material), contraindications may vary. This information can be found in the instruction for use of the devices.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtotal hip arthroplasty

hip replacement surgery


Locations(13)

CHU de Bordeaux - Hôpital Pellegrin

Bordeaux, France

Clinique des Cèdres

Cornebarrieu, France

Centre Ostéo-Articulaire des Cèdres

Échirolles, France

Hôpital privé Drôme Ardèche

Guilherand-Granges, France

Clinique du Croisé Laroche

Marcq-en-Barœul, France

Polyclinique Saint George

Nice, France

Groupe Hospitalier Diaconesses Croix Saint-Simon

Paris, France

CHU de Poitiers

Poitiers, France

Clinique de l'Atlantique

Puilboreau, France

CHU St Etienne, Hôpital Nord

Saint-Etienne, France

Polyclinique Sainte Thérèse

Sète, France

Clinique de l'Orangerie

Strasbourg, France

Hôpital privé du Vert Galant

Tremblay-en-France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05044767